Ultralife Corporation (NASDAQ:ULBI – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $6.26 and traded as high as $7.63. Ultralife shares last traded at $7.48, with a volume of 20,166 shares trading hands.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Ultralife in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.
View Our Latest Report on Ultralife
Ultralife Price Performance
Ultralife (NASDAQ:ULBI – Get Free Report) last posted its quarterly earnings results on Tuesday, March 10th. The technology company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.12). The business had revenue of $48.48 million for the quarter, compared to analysts’ expectations of $57.00 million. Ultralife had a positive return on equity of 3.10% and a negative net margin of 3.09%.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the business. Empowered Funds LLC purchased a new position in shares of Ultralife during the fourth quarter worth approximately $44,000. XTX Topco Ltd raised its stake in shares of Ultralife by 19.9% during the fourth quarter. XTX Topco Ltd now owns 15,456 shares of the technology company’s stock worth $88,000 after acquiring an additional 2,569 shares in the last quarter. Rothschild Wealth LLC purchased a new position in shares of Ultralife during the fourth quarter worth approximately $400,000. Heron Bay Capital Management purchased a new position in shares of Ultralife during the fourth quarter worth approximately $127,000. Finally, Jane Street Group LLC purchased a new position in shares of Ultralife during the fourth quarter worth approximately $75,000. 30.68% of the stock is owned by hedge funds and other institutional investors.
About Ultralife
Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.
Read More
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.
